Drug Trial Radar · NCT04651634
MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients
Last checked: Nov 19, 2026Latest source record: Apr 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jun 21, 2021
Primary completion
Dec 31, 2025
Study completion Dec 31, 2025
Sponsor
- Lead sponsor
- MitoImmune TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 3, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The proposed study in patients with previously untreated locally advanced head and neck squamous cell carcinoma (HNSCC) is designed to evaluate the efficacy and safety of three different doses of MIT-001 compared to the placebo in prevention of oral mucositis (OM) in patients with HNSCC who are undergoing concurrent chemoradiotherapy (CCRT).
Conditions
- Head and Neck Squamous Cell Carcinoma
- Oral Mucositis
Interventions
MIT-001 plus CCRTDrug
MIT-001 IV-infusion plus CCRT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of severe OMTime frame: From first treatment to 2 months of safety follow-up period after CCRT completion
Locations
16 sites in 2 countries. Site status is shown where the registry gives one.
Banner MD Anderson Cancer Center
Gilbert, Arizona
Norris Comprehensive Cancer Center
Los Angeles, California
Cancer Center of Kansas
Wichita, Kansas
James P. Wilmot Cancer Center
Rochester, New York
Wake Forest Baptist Health - Comprehensive Cancer Center
Winston-Salem, North Carolina
James Cancer Hospital Solove Research Institute
Columbus, Ohio
Keimyung University Dongsan Hospital
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
National Cancer Center
Goyang-si, South Korea
Seoul National University Bundang Hospital
Gyeonggi-do, South Korea
Inha University Hospital
Incheon, South Korea
Seoul National University Hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Hanyang University Seoul Hospital
Seoul, South Korea
The Catholic University of Korea Saint Vincent's Hospital
Suwon, Gyeonggi-do, South Korea
Jeonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.